S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Ride the Waves of Wealth With This Oil Tanker 17% Yield
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
BREAKING: Tiny biotech successfully treats blindness (Ad)
Peloton and Lululemon, Does the Deal Make Sense?
2 Seasonal Stocks to Warm Up Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
Sam Bankman-Fried must now convince a jury that the former crypto king was not a crook
Followed 113 TimesTop FollowedTop-Rated StocksTop-RatedMost-Upgraded StocksMost-Upgraded
NYSE:LLY

Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts

$537.97
+0.84 (+0.16%)
(As of 10/2/2023 ET)
Compare
Today's Range
$526.81
▼
$540.64
50-Day Range
$449.16
▼
$599.54
52-Week Range
$309.20
▼
$601.84
Volume
2.81 million shs
Average Volume
2.80 million shs
Market Capitalization
$510.69 billion
P/E Ratio
74.82
Dividend Yield
0.84%
Price Target
$532.78
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 7Estimated
Actual EPS
(Aug. 8)
$2.11 Beat By $0.13
Consensus EPS
(Aug. 8)
$1.98
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LLY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LLY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eli Lilly and Company Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$1.53$1.91$1.72 
Q2 20234$1.93$2.11$1.99 
Q3 20234$2.29$3.21$2.67 
Q4 20234$2.50$3.16$2.82 
FY 202315$8.25$10.39$9.19 
Q1 20242$2.28$2.74$2.51 
Q2 20242$2.81$2.89$2.85 
Q3 20242$2.93$3.63$3.28 
Q4 20242$3.04$3.72$3.38 
FY 20248$11.06$12.98$12.02 
Q1 20251$3.17$3.17$3.17 
Q2 20251$3.69$3.69$3.69 

LLY Earnings Date and Information

Eli Lilly and Company last posted its quarterly earnings data on August 8th, 2023. The reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.13. The business earned $8.31 billion during the quarter, compared to analysts' expectations of $7.58 billion. Its quarterly revenue was up 28.1% compared to the same quarter last year. Eli Lilly and Company has generated $7.19 earnings per share over the last year ($7.19 diluted earnings per share) and currently has a price-to-earnings ratio of 74.8. Earnings for Eli Lilly and Company are expected to grow by 33.23% in the coming year, from $9.84 to $13.11 per share. Eli Lilly and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off prior year's report dates.

Eli Lilly and Company Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/7/2023
Estimated)		------- 
8/8/2023Q2 2023$1.98$2.11+$0.13$2.27$7.58 billion$8.31 billion      
4/27/2023Q1 2023$1.73$1.62($0.11)$1.75$6.87 billion$6.96 billion    
2/2/2023Q4 2022$1.83$2.09+$0.26$2.04$7.39 billion$7.30 billion    
11/1/2022Q3 2022$1.97$1.98+$0.01$2.35$6.91 billion$6.94 billion
8/4/2022Q2 2022$1.80$1.25($0.55)$1.45$6.85 billion$6.49 billion      
4/28/2022Q1 2022$2.32$2.62+$0.30$3.14$7.29 billion$7.81 billion      
2/3/2022Q4 2021$2.51$2.49($0.02)$3.08$7.89 billion$8.00 billion    
10/25/2021Q3 2021$1.98$1.94($0.04)$2.66$6.64 billion$6.77 billion    
8/2/2021Q2 2021$1.89$1.87($0.02)$2.21$6.59 billion$6.74 billion      
4/26/2021Q1 2021$2.12$1.87($0.25)$2.25$7.10 billion$6.81 billion    
1/28/2021Q4 2020$2.35$2.75+$0.40$3.18$7.27 billion$7.44 billion  
11/1/2020Q3 2020$1.71$1.54($0.17)$1.75$5.87 billion$5.74 billion    












Eli Lilly and Company Earnings - Frequently Asked Questions

When is Eli Lilly and Company's earnings date?

Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off last year's report dates. Learn more on LLY's earnings history.

Did Eli Lilly and Company beat their earnings estimates last quarter?

In the previous quarter, Eli Lilly and Company (NYSE:LLY) reported $2.11 earnings per share (EPS) to beat the analysts' consensus estimate of $1.98 by $0.13. Learn more on analysts' earnings estimate vs. LLY's actual earnings.

How can I listen to Eli Lilly and Company's earnings conference call?

The conference call for Eli Lilly and Company's latest earnings report can be listened to online. Listen to Conference Call

How can I read Eli Lilly and Company's conference call transcript?

The conference call transcript for Eli Lilly and Company's latest earnings report can be read online. Read Transcript

How can I view Eli Lilly and Company's earnings report?

Eli Lilly and Company's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Eli Lilly and Company generate each year?

Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $28.54 billion.

How much profit does Eli Lilly and Company generate each year?

Eli Lilly and Company (NYSE:LLY) has a recorded net income of $6.24 billion. LLY has generated $7.19 earnings per share over the last four quarters.

What is Eli Lilly and Company's price-to-earnings ratio?

Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 74.82 and a forward price-to-earnings ratio of 54.67. The price/earnings-to-growth ratio is 2.21.

What is Eli Lilly and Company's EPS forecast for next year?

Eli Lilly and Company's earnings are expected to grow from $9.84 per share to $13.11 per share in the next year, which is a 33.23% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:LLY) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -